MarketPeel
Insider Trading Intelligence
BZ

Bernhardt G. Zeiher

TRDA
DIRECTOR · ENTRADA THERAPEUTICS, INC. · CIK 0001971421
FILING MIX · LIFETIME100%/0%
BUYS
13
SELLS
0
TOTAL VALUE
$66.3K
COMPANIES
3
ACTIVE SINCE
Apr 2023
HOLDINGS NOW
127,830
AVG SELL PX
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Bernhardt G. Zeiher, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+3.75%+0.58%+3.17%+3.17%
14d1+0.00%-5.90%-4.81%-1.09%-1.09%
30d1+100.00%+6.70%-6.63%+13.33%+13.33%
60d1+100.00%+43.70%+5.51%+38.19%+38.19%
90d1+100.00%+36.73%+5.97%+30.76%+30.76%
180d1+100.00%+220.64%+17.06%+203.58%+203.58%
1y1+100.00%+270.24%+15.04%+255.21%+255.21%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TRDA · 19,000 shares · as of Jun 10, 2026
08,00016,00024,00032,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 10, 2026Jun 12, 2026View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,37224,372Jun 4, 2026Jun 8, 2026View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
5,000$5.86$29.3K5,000May 20, 2026May 21, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
37,31384,458Jan 26, 2026Jan 27, 2026View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 11, 2025Jun 12, 2025View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 5, 2025Jun 9, 2025View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASE
10,000$3.70$37.0K10,000Mar 20, 2025Mar 24, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
36,10147,145Jan 31, 2025Feb 3, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
11,04411,044Aug 13, 2024Aug 14, 2024View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,00016,000Jun 13, 2024Jun 14, 2024View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,7535,753Jun 6, 2024Jun 7, 2024View →
AMLX
AMYLYX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Mar 14, 2024Mar 15, 2024View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Apr 4, 2023Apr 4, 2023View →
Other insiders · TRDA
Loading peer insiders…
About this filer
CIK 0001971421
ROLE
Director
PRIMARY
TRDA
COMPANIES
3
ACTIVE SINCE
Apr 2023
MARKETPEEL · /INSIDER/0001971421DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback